Cargando…
5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information
BACKGROUND: Colorectal cancer is a commonly diagnosed cancer worldwide. Unfortunately, many patients do not respond to standard chemotherapy treatments and develop disease relapse and metastases. Besides cancer cell specific genetic changes, heterogeneity in the tumor microenvironment contribute to...
Autores principales: | Salerno, Simona, Ståhlberg, Anders, Holdfeldt, André, Bexe Lindskog, Elinor, Landberg, Göran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102939/ https://www.ncbi.nlm.nih.gov/pubmed/35562738 http://dx.doi.org/10.1186/s12967-022-03423-6 |
Ejemplares similares
-
Patient‐derived scaffolds as a model of colorectal cancer
por: Parkinson, Gabrielle T., et al.
Publicado: (2020) -
Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer
por: Gustafsson, Anna, et al.
Publicado: (2021) -
Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer
por: Lindskog, Elinor Bexe, et al.
Publicado: (2014) -
Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival
por: Salimzadeh, Hamideh, et al.
Publicado: (2020) -
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer
por: Kaidi, Donia, et al.
Publicado: (2022)